HK:9939 Stock Latest News
Company AnnouncementsKintor Completes Long-Term Safety Trial for KX-826 in China6h ago9939
Company AnnouncementsKintor Steps Up Cash-Flow Measures as KX-826 and KOSHINÉ Drive Growth3d ago9939
Company AnnouncementsKintor Wins China Patent for Core Skin-Whitening Ingredient KT-9391w ago9939
Company AnnouncementsKintor Pharma Reshapes Finance Leadership With New CFO and Process Agent1M ago9939
Company AnnouncementsKintor completes year-long safety trial for whitening ingredient KT-9391M ago9939
Company AnnouncementsKintor Pharmaceutical Boosts Revenue on Cosmetics Push but Stays in the Red2M ago9939Company AnnouncementsKintor Pharmaceutical Sets Board Meeting to Approve 2026 Interim Results2M ago9939
Company AnnouncementsKintor Moves to Resolve Going-Concern Audit Issue With KX-826 Commercial Push3M ago9939
Company AnnouncementsKintor Pharmaceutical Wins Strong Shareholder Backing at 2026 AGM4M ago9939
Company AnnouncementsKintor Advances KT-939 Cosmetic Raw Material With Strong Safety Data and China Registration Push4M ago9939
Company AnnouncementsKintor Showcases Promising KX-826 Hair Loss Data as It Pursues First-in-Class Status5M ago9939
Company AnnouncementsKintor CEO Boosts Stake, Signaling Confidence in Hair-Loss Drug Pipeline5M ago9939
Company AnnouncementsKintor Pharmaceutical Sets 2026 AGM to Approve Accounts, Board Changes and Share Issuance Mandate5M ago9939Company AnnouncementsKintor Pharma to Rotate Auditor, Taps Rongcheng HK to Replace PwC in 20265M ago9939
Company AnnouncementsKintor Pharmaceutical Surges in E‑commerce and B2B Sales to Fund Core Drug Pipeline6M ago9939
Company AnnouncementsKintor’s Cosmetics-Driven Revenue Soars but Loss Widens on Pipeline Shift7M ago9939- Company AnnouncementsKintor Pharmaceutical Delays Board Meeting to Approve 2025 Annual Results7M ago9939
Company AnnouncementsKintor’s KX-826 Hits Phase III Goal in China AGA Trial, NDA Planned7M ago9939
Company AnnouncementsKintor Ties Up With Chicmax to Commercialize KT-939 Whitening Ingredient and Fund Core Drug Pipeline7M ago9939Company AnnouncementsKintor Partners With Fonow Medicine to Commercialize KT-939 Functional Cosmetics in China7M ago9939
Company AnnouncementsKintor Reaffirms Drug R&D Focus as Cosmetics Remain Ancillary Revenue Stream8M ago9939
